View up-to-date information on Applied Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4041219A1 | Application | ALDOSE-REDUKTASE-INHIBITOREN ZUR BEHANDLUNG VON PHOSPHOMANNOMUTASE-2-MANGEL | A61K31/5025; A61P25/00 | August 17, 2022 |
US20220226323A1 | Application | ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF PHOSPHOMANNOMUTASE 2 DEFICIENCY | A61K31/5025 | July 21, 2022 |
IL291946D0 | Application | Aldose reductase inhibitors for treatment of phosphomannomutase 2 deficiency | A61K31/5025; A61P25/00 | June 01, 2022 |
IL291946A | Application | Aldose reductase inhibitors for treatment of phosphomannomutase 2 deficiency | A61K31/5025; A61P25/00 | June 01, 2022 |
AU2020363699A1 | Application | Aldose reductase inhibitors for treatment of phosphomannomutase 2 deficiency | A61K31/5025; A61P25/00 | May 26, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer